Full video transcriptClick to expand
Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00When you take testosterone replacement therapy,
- 0:01does your body stop producing testosterone?
- 0:03If you were to only take injectable testosterone,
- 0:06your body does stop making testosterone.
- 0:08But this is a very old school way
- 0:09of testosterone replacement therapy.
- 0:11In modern medicine, injectable testosterone
- 0:13is done at a lower dose,
- 0:14and other supplements are added
- 0:15into help boost your natural production of testosterone,
- 0:18while also keeping your natural production going.
- 0:20The two most common supplements
- 0:21use are N-clomaphine and HCG.
- 0:23They essentially do the same exact thing,
- 0:25but N-clomaphine is in pill form,
- 0:27and HCG is an injectable form.
- 0:29I take N-clomaphine three times a week at 25 milligrams,
- 0:32and as of right now,
- 0:32my body is still producing its own natural testosterone.
- 0:35I don't have any shrinkage whatsoever,
- 0:37and I'm still able to maintain fertility
- 0:38while on testosterone replacement therapy.
- 0:40Hopefully this clears that up for you guys.
- 0:42If you have low testosterone
- 0:43and you're interested in starting testosterone replacement therapy,
- 0:45reach out to me and I'll make sure you get the resources
- 0:47to begin your journey of TRT online.
- 0:49And until next time, hit the plus sign, let's go.
Does TRT actually shut down natural testosterone production?
Quick answer
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing endogenous LH, FSH, and intratesticular testosterone, which can impair spermatogenesis and cause testicular atrophy. Co-administration of HCG or enclomiphene is used in some TRT protocols to partially preserve HPG axis activity, though these agents work through distinct mechanisms and are not pharmacologically equivalent. Fertility preservation on TRT requires individualized evaluation by a licensed clinician, including baseline and follow-up semen analysis.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does TRT actually shut down natural testosterone production?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does TRT actually shut down natural testosterone production? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Does TRT actually shut down natural testosterone production?" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing endogenous LH, FSH, and intratesticular testosterone, which can impair spermatogenesis and cause testicular atrophy.
The reason this review is not generic is the source wording and the canonical claim label "trt does trt stop natural production testosterone replacement th." In this clip, the useful excerpt is: "When you take testosterone replacement therapy, does your body stop producing testosterone?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing endogenous LH, FSH, and intratesticular testosterone, which can impair spermatogenesis and cause testicular atrophy.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing endogenous LH, FSH, and intratesticular testosterone, which can impair spermatogenesis and cause testicular atrophy. Co-administration of HCG or enclomiphene is used in some TRT protocols to partially preserve HPG axis activity, though these agents work through distinct mechanisms and are not pharmacologically equivalent. Fertility preservation on TRT requires individualized evaluation by a licensed clinician, including baseline and follow-up semen analysis.
- Exogenous testosterone suppresses the HPG axis in all men; Kim et al. (2013, Journal of Urology) documented measurable testicular volume loss without co-treatment.
- HCG and enclomiphene address this suppression through different mechanisms: HCG acts at the testes directly, enclomiphene acts upstream at the hypothalamus.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Exogenous testosterone suppresses the HPG axis in all men; Kim et al. (2013, Journal of Urology) documented measurable testicular volume loss without co-treatment.
- HCG and enclomiphene address this suppression through different mechanisms: HCG acts at the testes directly, enclomiphene acts upstream at the hypothalamus.
- Wiehle et al. (2014, Andrology) showed enclomiphene raises both LH and FSH, while HCG raises testosterone but does not reliably increase FSH, which matters for sperm production.
- Enclomiphene is not FDA-approved for male use in the US and is typically dispensed through compounding pharmacies, meaning product quality is not federally standardized.
- Any man on TRT who wants to preserve fertility should get a semen analysis before starting and at follow-up intervals, not rely on the absence of visible symptoms.
- The creator has an undisclosed financial interest in referring viewers to online TRT services, which is relevant context for evaluating his recommendations.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The creator's core claim is straightforward: yes, TRT suppresses natural testosterone production, but pairing injectable testosterone with either enclomiphene or HCG can keep your body's own production running. He calls solo injectable TRT "old school" and says modern protocols use lower doses plus these add-ons. He also states he personally takes enclomiphene three times a week at 25mg and has experienced no testicular atrophy and has maintained fertility.
One thing to flag immediately: he calls the drug "N-clomaphine" throughout, which appears to be a pronunciation error. The compound he is describing is enclomiphene citrate, a selective estrogen receptor modulator (SERM). This is worth clarifying because people searching for information after watching this video may not find what they need.
Does the science back this up?
Partially, yes. The suppression claim is solid. Exogenous testosterone reliably suppresses the hypothalamic-pituitary-gonadal (HPG) axis. Your brain detects circulating testosterone, stops releasing GnRH, and LH and FSH levels drop. Without LH stimulation, the testes reduce production and can physically shrink. This is not controversial. Kim et al. (2013, Journal of Urology) documented significant testicular volume loss in men on exogenous testosterone without co-treatment.
Where things get more complicated is the "enclomiphene and HCG do essentially the same exact thing" claim. They do both stimulate testosterone production, but through different mechanisms. HCG mimics LH directly at the testicular receptor. Enclomiphene blocks estrogen receptors in the hypothalamus, which increases endogenous LH and FSH secretion. That upstream vs. downstream difference matters clinically. Wiehle et al. (2014, Andrology) showed enclomiphene raised testosterone and LH simultaneously, while HCG raises testosterone but suppresses LH. Saying they are "the same exact thing" oversimplifies a meaningful pharmacological difference.
What did they get wrong (or right)?
Credit where it is due: the creator is right that HPG axis suppression is a real and documented side effect of TRT, and right that co-treatments exist to address it. This is not fringe information. Fertility preservation on TRT is a legitimate clinical concern, and the conversation around it has matured significantly. Pointing people toward that reality is genuinely useful.
What he got wrong: the equivalency framing. Enclomiphene and HCG do not "do the same exact thing." HCG works peripherally at the testes; enclomiphene works centrally at the hypothalamus. Their FSH profiles differ, which matters for sperm production. A man primarily concerned with fertility might respond differently to each option. Coviello et al. (2004, Journal of Clinical Endocrinology and Metabolism) showed HCG maintains intratesticular testosterone but does not necessarily preserve FSH-driven spermatogenesis the way a SERM can.
He also promotes himself as a referral source for starting TRT online, which is a commercial interest disclosure that is absent from the video. Viewers should know that context.
What should you actually know?
If you are on TRT and care about fertility or testicular function, the research supports asking your prescriber about adjunct options. That conversation should happen with a licensed clinician who can review your labs, not based on a TikTok anecdote. Enclomiphene is not FDA-approved for use in men and is available through compounding pharmacies in the US, which means quality and dosing consistency can vary. That is a real limitation the video does not mention.
The idea that "modern" TRT always includes these adjuncts is also not universally true. Many protocols are individualized. Some men on TRT are not concerned with fertility preservation and do fine without adjunct therapy. Blanket statements about what constitutes current standard practice can set inaccurate expectations.
- Suppression of the HPG axis on TRT is real and well-documented.
- Adjunct therapies like HCG and enclomiphene can mitigate this, but they are not interchangeable.
- Anyone starting TRT should have a baseline semen analysis if fertility matters to them.
- Enclomiphene's regulatory status and compounding variability are relevant considerations a video like this omits.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
132.0K views on this video
Does TRT stop natural production? (Testosterone Replacement Therapy Side Effects) #testosteronereplacementtherapy #testosteronetherapy #hormonereplacementtherapy #testosterone
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about exogenous testosterone suppresses the hpg axis in all men; kim?
Exogenous testosterone suppresses the HPG axis in all men; Kim et al. (2013, Journal of Urology) documented measurable testicular volume loss without co-treatment.
What does the video say about hcg?
HCG and enclomiphene address this suppression through different mechanisms: HCG acts at the testes directly, enclomiphene acts upstream at the hypothalamus.
What does the video say about wiehle et al. (2014, andrology) showed enclomiphene raises both lh?
Wiehle et al. (2014, Andrology) showed enclomiphene raises both LH and FSH, while HCG raises testosterone but does not reliably increase FSH, which matters for sperm production.
What does the video say about enclomiphene?
Enclomiphene is not FDA-approved for male use in the US and is typically dispensed through compounding pharmacies, meaning product quality is not federally standardized.
What does the video say about any man on trt who wants to preserve fertility should?
Any man on TRT who wants to preserve fertility should get a semen analysis before starting and at follow-up intervals, not rely on the absence of visible symptoms.
What does the video say about the creator has an undisclosed financial interest in referring viewers?
The creator has an undisclosed financial interest in referring viewers to online TRT services, which is relevant context for evaluating his recommendations.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.